Deepak Bhattarai

738 total citations
25 papers, 466 citations indexed

About

Deepak Bhattarai is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Deepak Bhattarai has authored 25 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Deepak Bhattarai's work include Synthesis and biological activity (6 papers), Alzheimer's disease research and treatments (5 papers) and Ubiquitin and proteasome pathways (4 papers). Deepak Bhattarai is often cited by papers focused on Synthesis and biological activity (6 papers), Alzheimer's disease research and treatments (5 papers) and Ubiquitin and proteasome pathways (4 papers). Deepak Bhattarai collaborates with scholars based in South Korea, United States and Yemen. Deepak Bhattarai's co-authors include Kyeong Lee, Xuezhen Xu, Sarbjit Singh, Yongseok Choi, Kyung Bo Kim, Min Jae Lee, Zachary Miller, Sukyeong Lee, Yongseok Choi and Dong‐Eun Kim and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Deepak Bhattarai

25 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deepak Bhattarai South Korea 13 272 129 95 93 40 25 466
Ming Guo China 8 353 1.3× 132 1.0× 134 1.4× 44 0.5× 45 1.1× 14 540
Najah Albadari United States 7 269 1.0× 78 0.6× 119 1.3× 209 2.2× 34 0.8× 16 476
José María Zapico Spain 14 206 0.8× 96 0.7× 138 1.5× 136 1.5× 22 0.6× 28 407
Lori K. Gavrin United States 8 218 0.8× 126 1.0× 68 0.7× 39 0.4× 35 0.9× 9 386
Debasish Paul India 14 314 1.2× 53 0.4× 112 1.2× 67 0.7× 35 0.9× 28 462
Koc-Kan Ho United States 12 328 1.2× 64 0.5× 73 0.8× 82 0.9× 31 0.8× 17 476
Aaron Maurais United States 7 204 0.8× 80 0.6× 71 0.7× 56 0.6× 95 2.4× 8 364
Daniel J. Burdick United States 13 353 1.3× 96 0.7× 77 0.8× 46 0.5× 47 1.2× 19 613
Irene Filippi Italy 15 252 0.9× 125 1.0× 102 1.1× 129 1.4× 141 3.5× 29 618
Jean‐François Gaussin Belgium 7 343 1.3× 134 1.0× 114 1.2× 80 0.9× 41 1.0× 10 587

Countries citing papers authored by Deepak Bhattarai

Since Specialization
Citations

This map shows the geographic impact of Deepak Bhattarai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepak Bhattarai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepak Bhattarai more than expected).

Fields of papers citing papers by Deepak Bhattarai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepak Bhattarai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepak Bhattarai. The network helps show where Deepak Bhattarai may publish in the future.

Co-authorship network of co-authors of Deepak Bhattarai

This figure shows the co-authorship network connecting the top 25 collaborators of Deepak Bhattarai. A scholar is included among the top collaborators of Deepak Bhattarai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deepak Bhattarai. Deepak Bhattarai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Park, Ji Eun, et al.. (2024). Brain-Permeable Immunoproteasome-Targeting Macrocyclic Peptide Epoxyketones for Alzheimer’s Disease. Journal of Medicinal Chemistry. 67(9). 7146–7157. 6 indexed citations
3.
Lee, Min Jae, Deepak Bhattarai, In Jun Yeo, et al.. (2021). Macrocyclic Immunoproteasome Inhibitors as a Potential Therapy for Alzheimer’s Disease. Journal of Medicinal Chemistry. 64(15). 10934–10950. 11 indexed citations
4.
Kim, Dae Gyu, Deepak Bhattarai, Minkyoung Kim, et al.. (2020). Synthesis and Structure–Activity Relationships of Arylsulfonamides as AIMP2-DX2 Inhibitors for the Development of a Novel Anticancer Therapy. Journal of Medicinal Chemistry. 63(10). 5139–5158. 19 indexed citations
5.
Bhattarai, Deepak, Min Jae Lee, Ahruem Baek, et al.. (2020). LMP2 Inhibitors as a Potential Treatment for Alzheimer’s Disease. Journal of Medicinal Chemistry. 63(7). 3763–3783. 24 indexed citations
6.
Lee, Min Jae, Zachary Miller, Ji Eun Park, et al.. (2019). H727 cells are inherently resistant to the proteasome inhibitor carfilzomib, yet require proteasome activity for cell survival and growth. Scientific Reports. 9(1). 4089–4089. 12 indexed citations
7.
Yeo, In Jun, Min Jae Lee, Ahruem Baek, et al.. (2019). A dual inhibitor of the proteasome catalytic subunits LMP2 and Y attenuates disease progression in mouse models of Alzheimer’s disease. Scientific Reports. 9(1). 18393–18393. 22 indexed citations
8.
Lim, Semi, Dae Gyu Kim, Ameeq Ul Mushtaq, et al.. (2019). Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development. Nature Chemical Biology. 16(1). 31–41. 38 indexed citations
9.
Lee, Min Jae, Deepak Bhattarai, Jisu Yoo, et al.. (2019). Development of Novel Epoxyketone-Based Proteasome Inhibitors as a Strategy To Overcome Cancer Resistance to Carfilzomib and Bortezomib. Journal of Medicinal Chemistry. 62(9). 4444–4455. 22 indexed citations
10.
Bhattarai, Deepak, Joo Hyun Jung, Hankyu Lee, et al.. (2016). Design, synthesis, and biological evaluation of structurally modified isoindolinone and quinazolinone derivatives as hedgehog pathway inhibitors. European Journal of Medicinal Chemistry. 125. 1036–1050. 20 indexed citations
11.
Bhattarai, Deepak, et al.. (2016). An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs. Current Topics in Medicinal Chemistry. 16(19). 2156–2168. 24 indexed citations
12.
13.
Kim, Beom Seok, Kyeong Lee, Hye Jin Jung, Deepak Bhattarai, & Ho Jeong Kwon. (2015). HIF-1α suppressing small molecule, LW6, inhibits cancer cell growth by binding to calcineurin b homologous protein 1. Biochemical and Biophysical Research Communications. 458(1). 14–20. 24 indexed citations
14.
Bhattarai, Deepak, Soon Bang Kang, Youseung Kim, et al.. (2015). Synthesis and biological evaluation of isoxazoline derivatives as potent M1 muscarinic acetylcholine receptor agonists. Bioorganic & Medicinal Chemistry Letters. 25(7). 1546–1551. 9 indexed citations
15.
Bhattarai, Deepak, et al.. (2015). Phytosphingosine promotes megakaryocytic differentiation of myeloid leukemia cells. BMB Reports. 48(12). 691–695. 13 indexed citations
16.
Bhattarai, Deepak, Muhammad Muddassar, Jae Young Jang, et al.. (2015). Virtual Screening and Synthesis of Novel Antitubercular Agents Through Interaction-Based Pharmacophore and Molecular Docking Studies. Current Computer - Aided Drug Design. 10(4). 383–392. 2 indexed citations
17.
Singh, Sarbjit, et al.. (2015). Recent Advances in the Development of Pharmacologically Active Compounds that Contain a Benzoxazole Scaffold. Asian Journal of Organic Chemistry. 4(12). 1338–1361. 59 indexed citations
18.
Bhattarai, Deepak & Sun Hee Lee. (2014). Synthesis and Antibacterial Activity of Novel 2-Oxo-pyrrolidinyl Oxazolidinones. YUHSpace (Yonsei University Medical Library). 2 indexed citations
19.
20.
Bhattarai, Deepak, Sun H. Lee, Ghilsoo Nam, et al.. (2012). Synthesis and In Vitro Antibacterial Activity of Novel 3‐Azabicyclo[3.3.0]octanyl Oxazolidinones. Chemical Biology & Drug Design. 80(3). 388–397. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ming Guo Breakdown of academic impact, for papers by Najah Albadari Breakdown of academic impact, for papers by José María Zapico Breakdown of academic impact, for papers by Lori K. Gavrin Breakdown of academic impact, for papers by Debasish Paul Breakdown of academic impact, for papers by Koc-Kan Ho Breakdown of academic impact, for papers by Aaron Maurais Breakdown of academic impact, for papers by Daniel J. Burdick Breakdown of academic impact, for papers by Irene Filippi Breakdown of academic impact, for papers by Jean‐François Gaussin
Rankless by CCL
2026